LITTLE FALLS, N.J.
, Nov. 6, 2013
/PRNewswire/ -- CANTEL MEDICAL CORP.
(NYSE: CMN), has further enhanced its leading endoscopy product portfolio with the acquisition of Jet Prep Ltd. Based in Herzliya, Israel
, Jet Prep Ltd. is the developer of the Jet Prep Flushing Device, a novel single-use irrigation and aspiration catheter to improve visualization during colonoscopy procedures. The Jet Prep Flushing Device has FDA 510(k) and CE Mark clearances and is ready for immediate commercialization by our global endoscopy sales forces. The Jet Prep operation, which will be integrated into our Medivators Endoscopy business, will remain in Israel. Led by David Nitsan
, this group of R&D engineers will continue working on new product development.
Don Byrne, President of Medivators Endoscopy, stated, "This acquisition strengthens our position as a leading provider of novel products and solutions for GI endoscopy. The Jet Prep product is an important addition to our growing portfolio of endoscopy products focused on infection control and improving patient safety and outcomes."
Cantel Medical's Executive Vice President and COO, Jorgen Hansen, added, "We see the Jet Prep product line as exactly the type of novel and highly differentiated product that Medivators should be introducing to the market. We know there is strong demand from physicians for a unique solution to improving visualization and have high expectations for its success in the GI endoscopy market. We remain confident in the continued strong growth of our Medivators Endoscopy business."
About Cantel Medical Corp.
Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
SOURCE Cantel Medical Corp.